Overview

Novel Approaches for Improving Vascular Function in Veterans With HFpEF

Status:
RECRUITING
Trial end date:
2030-09-30
Target enrollment:
Participant gender:
Summary
This project will evaluate the impact of L-Citrulline, tetrahydrobiopterin (BH4), and atorvastatin administration on physical capacity and vascular function in Veterans with heart failure with preserved ejection fraction (HFpEF).
Phase:
PHASE1
Details
Lead Sponsor:
VA Office of Research and Development
Collaborator:
University of Utah
Treatments:
Atorvastatin
Citrulline
sapropterin